Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Statement on December 2025 ACIP Meeting

December 5, 2025

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory Committee on Immunization Practices (ACIP) has…

BIO Statement on the Retirement of Richard Pazdur from US FDA

December 2, 2025

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career to public service and the needs of patients. He…

BIO Statement on House Passage of Mikaela Naylon Give Kids a Chance Act

December 1, 2025

WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon Give Kids a Chance Act is a victory for children and…